Gynecology & Obstetrics Case report Open Access

  • ISSN: 2471-8165
  • Journal h-index: 7
  • Journal CiteScore: 0.44
  • Journal Impact Factor: 0.48
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us 44-7723-850004

Abstract

Gynecologic Malignancies have Tumor-associated Macrophages: A Mini Review

Zyan Hadhi* and Asraf Qureshi

In gynecologic malignancies, the intricate tumor microenvironment is a significant modulator of anti-tumor immune responses. The effectiveness of conventional chemotherapy and cutting-edge immunotherapy techniques is significantly impacted by how cancer cells interact with the wide range of immune effector cells. We pay particular attention to the function of macrophages in ovarian, endometrial, and cervical malignancies in this review. We talk about how macrophages developed and how the stimuli from their microenvironment determine their polarization status. Tumor-associated macrophages (TAMs) within the tumor niche influence treatment outcomes by promoting tumor development and mediating immune-suppression. We describe clinical tactics that specifically target TAMs, such as blocking immunological checkpoints, preventing monocyte recruitment to the tumor, enhancing phagocytosis, and inhibiting macrophage differentiation.

Published Date: 2022-08-01; Received Date: 2022-07-06